Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
126.67
+1.57 (1.26%)
Nov 22, 2024, 4:00 PM EST - Market closed
Jazz Pharmaceuticals Employees
Jazz Pharmaceuticals had 2,800 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
2,800
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,425,969
Profits / Employee
$165,414
Market Cap
7.66B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2,800 | 0 | - |
Dec 31, 2022 | 2,800 | -400 | -12.50% |
Dec 31, 2021 | 3,200 | 1,260 | 64.95% |
Dec 31, 2020 | 1,940 | 320 | 19.75% |
Dec 31, 2019 | 1,620 | 260 | 19.12% |
Dec 31, 2018 | 1,360 | 150 | 12.40% |
Dec 31, 2017 | 1,210 | 170 | 16.35% |
Dec 31, 2016 | 1,040 | 130 | 14.29% |
Dec 31, 2015 | 910 | 40 | 4.60% |
Dec 31, 2014 | 870 | 60 | 7.41% |
Dec 31, 2013 | 810 | 200 | 32.79% |
Dec 31, 2012 | 610 | 179 | 41.53% |
Dec 31, 2011 | 431 | 189 | 78.10% |
Dec 31, 2010 | 242 | 14 | 6.14% |
Dec 31, 2009 | 228 | 12 | 5.56% |
Dec 31, 2008 | 216 | -193 | -47.19% |
Dec 31, 2007 | 409 | 224 | 121.08% |
Dec 31, 2007 | 185 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Walgreens Boots Alliance | 331,000 |
The Ensign Group | 35,300 |
Grifols | 23,737 |
Chemed | 15,087 |
Bausch + Lomb | 13,300 |
Legend Biotech | 1,826 |
Repligen | 1,783 |
Glaukos | 907 |
JAZZ News
- 2 days ago - Jazz Pharmaceuticals receives FDA approval for biliary tract cancer treatment - Reuters
- 2 days ago - Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC) - PRNewsWire
- 3 days ago - Jazz Pharmaceuticals to Participate in Citi's 2024 Global Healthcare Conference - PRNewsWire
- 16 days ago - Jazz Pharmaceuticals plc (JAZZ) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 16 days ago - Jazz Pharmaceuticals Reports Strong Q3: Will Debt Weigh On Its Future Growth? - Benzinga
- 16 days ago - Jazz Pharmaceuticals Announces Third Quarter 2024 Financial Results - PRNewsWire
- 22 days ago - Jazz Pharmaceuticals Presents New Data at Psych Congress 2024 Confirming Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Treatment Benefits in Narcolepsy and Idiopathic Hypersomnia - PRNewsWire
- 4 weeks ago - Jazz Pharmaceuticals to Report 2024 Third Quarter Financial Results on November 6, 2024 - PRNewsWire